Treatments Used Among Adolescent Residential Addiction Treatment Facilities in the US, 2022.
作者信息
King Caroline, Beetham Tamara, Smith Natashia, Englander Honora, Hadland Scott E, Bagley Sarah M, Korthuis P Todd
机构信息
Oregon Health & Science University School of Medicine, Portland.
Department of Health Policy and Management, Yale University, New Haven, Connecticut.
出版信息
JAMA. 2023 Jun 13;329(22):1983-1985. doi: 10.1001/jama.2023.6266.
Abstract
摘要
相似文献
1
Treatments Used Among Adolescent Residential Addiction Treatment Facilities in the US, 2022.2022年美国青少年住院戒毒治疗机构所采用的治疗方法
JAMA. 2023 Jun 13;329(22):1983-1985. doi: 10.1001/jama.2023.6266.
2
Racial and Ethnic Differences in Mental Health Service Use Among Adolescents.青少年心理健康服务使用中的种族和族裔差异。
JAMA Netw Open. 2025 Jun 2;8(6):e2516612. doi: 10.1001/jamanetworkopen.2025.16612.
3
Time Spent on Social Media and the Risk of Substance Use Among US Adolescents.美国青少年花在社交媒体上的时间与物质使用风险
J Adolesc. 2025 Jul;97(5):1314-1322. doi: 10.1002/jad.12498. Epub 2025 Apr 6.
4
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统，50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
5
Age Group Differences Among Adults Seeking Treatment for Opioid Use Disorder (OUD) in Rehabilitation/Residential Settings in the United States.
Am J Geriatr Psychiatry. 2025 Dec;33(12):1279-1289. doi: 10.1016/j.jagp.2025.06.007. Epub 2025 Jun 16.
6
The Impact of Medicaid Institutions for Mental Disease Exclusion Waivers on the Availability of Substance Abuse Treatment Services and the Varying Effect by Ownership Type.医疗补助精神疾病排除豁免对物质滥用治疗服务的可及性的影响以及所有权类型的不同影响。
Milbank Q. 2024 Sep;102(3):669-691. doi: 10.1111/1468-0009.12710. Epub 2024 Jul 5.
7
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.系统评价：阿片类药物治疗慢性背痛：患病率、疗效及与成瘾的关联
Ann Intern Med. 2007 Jan 16;146(2):116-27. doi: 10.7326/0003-4819-146-2-200701160-00006.
8
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.创伤后应激障碍及共病物质使用障碍的心理治疗
Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2.
9
Prevalence and services for the treatment of chronic pain at residential substance treatment centers.住院物质治疗中心慢性疼痛的患病率和治疗服务。
J Addict Dis. 2024 Oct-Dec;42(4):432-437. doi: 10.1080/10550887.2023.2251856. Epub 2023 Sep 4.
引用本文的文献
1
Prevention and Management of Opioid use Disorder and Overdose in Adolescents and Young Adults.青少年和青年阿片类药物使用障碍及过量用药的预防与管理
Curr Psychiatry Rep. 2025 Sep 12. doi: 10.1007/s11920-025-01638-0.
2
Adolescent Treatment Landscape of Depression, Suicidality, and Substance Use Disorder in the US.美国青少年抑郁症、自杀倾向及物质使用障碍的治疗现状
JAMA Health Forum. 2025 Aug 1;6(8):e252647. doi: 10.1001/jamahealthforum.2025.2647.
3
Perspectives from Systems-Level Key Informants on Optimizing Opioid Use Disorder Treatment for Adolescents and Young Adults.系统层面关键信息提供者对优化青少年和青年阿片类物质使用障碍治疗的看法
Children (Basel). 2025 Jul 2;12(7):876. doi: 10.3390/children12070876.
4
Hospital Provider's Perspectives on MOUD Initiation and Continuation After Inpatient Discharge.医院提供者对住院出院后启动和持续使用药物辅助治疗的看法。
J Gen Intern Med. 2024 Nov 25. doi: 10.1007/s11606-024-09008-x.
5
Opportunities to enhance retention on medication for opioid use disorder for adolescents and young adults: results from a qualitative study with medical providers in Philadelphia, PA.提高青少年和年轻成年人阿片类药物使用障碍药物治疗依从性的机会：来自宾夕法尼亚州费城医疗提供者的定性研究结果。
Harm Reduct J. 2024 Nov 25;21(1):210. doi: 10.1186/s12954-024-01113-8.
6
Clinician Willingness to Prescribe Medications for Opioid Use Disorder to Adolescents in Indiana.印第安纳州临床医生为青少年开阿片类药物使用障碍药物的意愿。
JAMA Netw Open. 2024 Sep 3;7(9):e2435416. doi: 10.1001/jamanetworkopen.2024.35416.
7
Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers.对阿片类药物使用障碍药物的态度和培训：青年法律系统和社区心理健康中心员工中的描述性分析。
Subst Abuse Treat Prev Policy. 2024 Jun 21;19(1):32. doi: 10.1186/s13011-024-00614-w.
8
The Overdose Crisis among U.S. Adolescents.美国青少年的药物过量危机。
N Engl J Med. 2024 Jan 11;390(2):97-100. doi: 10.1056/NEJMp2312084. Epub 2024 Jan 6.
9
Adolescent Residential Addiction Treatment In The US: Uneven Access, Waitlists, And High Costs.美国青少年住院成瘾治疗：机会不均等、候补名单和高成本。
Health Aff (Millwood). 2024 Jan;43(1):64-71. doi: 10.1377/hlthaff.2023.00777.
10
Medication Treatment for Youth in Substance Use Disorder Residential Treatment.物质使用障碍住院治疗青少年的药物治疗。
J Atten Disord. 2024 Mar;28(5):791-799. doi: 10.1177/10870547231218948. Epub 2024 Jan 3.
本文引用的文献
1
Equine-assisted services for individuals with substance use disorders: a scoping review.马术辅助服务在物质使用障碍者中的应用：综述
Subst Abuse Treat Prev Policy. 2022 Dec 14;17(1):81. doi: 10.1186/s13011-022-00506-x.
2
Medication for Adolescents and Young Adults With Opioid Use Disorder.青少年和青年阿片类药物使用障碍患者的药物治疗。
J Adolesc Health. 2021 Mar;68(3):632-636. doi: 10.1016/j.jadohealth.2020.12.129. Epub 2021 Jan 21.
3
Therapies Offered at Residential Addiction Treatment Programs in the United States.美国住院成瘾治疗计划提供的疗法。
JAMA. 2020 Aug 25;324(8):804-806. doi: 10.1001/jama.2020.8969.
4
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update.美国成瘾医学协会阿片类物质使用障碍治疗国家实践指南：2020年重点更新
J Addict Med. 2020 Mar/Apr;14(2S Suppl 1):1-91. doi: 10.1097/ADM.0000000000000633.
5
Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.2001-2014 年青少年和青年人群中阿片类物质使用障碍患者接受丁丙诺啡和纳曲酮治疗的趋势。
JAMA Pediatr. 2017 Aug 1;171(8):747-755. doi: 10.1001/jamapediatrics.2017.0745.
Zotero 插件